Genetic Signatures Limited (ASX:GSS)
0.0720
0.00 (0.00%)
Nov 11, 2026, 3:11 PM AEDT
Genetic Signatures Market Cap
Genetic Signatures has a market cap or net worth of 16.35 million as of November 16, 2026. It is the 40,737th most valuable company in the world and the 1,116th biggest in Australia. Its market cap has decreased by 77.50% in one year.
Market Cap
16.35M
Enterprise Value
-5.43M
Revenue
19.33M
Global Rank
Country Rank
#1,116 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since March 31, 2015, Genetic Signatures's market cap has decreased from 35.38M to 16.35M, a decrease of -53.77%. That is a compound annual growth rate of -6.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 16.35M | -71.20% |
| Dec 31, 2025 | 56.79M | -60.32% |
| Dec 31, 2024 | 143.10M | 99.47% |
| Dec 29, 2023 | 71.74M | -43.15% |
| Dec 30, 2022 | 126.20M | -50.73% |
| Dec 31, 2021 | 256.15M | -10.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Australian Clinical Labs | 619.90M |
| Healius | 417.54M |
| Monash IVF Group | 292.23M |
| Identifai Genetics | 80.63M |
| Cryosite | 59.55M |
| Microba Life Sciences | 25.21M |
| Rhythm Biosciences | 23.36M |
| BCAL Diagnostics | 22.12M |